Neutra Corp
Neutra Corp
  • Home
  • About Us
  • Companies
  • Investors
  • Contact Us
  • More
    • Home
    • About Us
    • Companies
    • Investors
    • Contact Us
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • About Us
  • Companies
  • Investors
  • Contact Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Stock Information

OTC Pink: NTRR

Press Releases

Neutra Corp - April 29, 2025

Neutra Corp's Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Neutra Corp - April 1, 2025

Neutra Corp Signs Letter of Intent to Acquire CuraConnector.com, Inc., Expanding Into Healthcare Information & Digital Technology 

Neutra Corp - March 13, 2025

Neutra Corp's Wholly Owned Subsidiary Neutra Life Sciences Inks Joint Venture Partnership

Neutra Corp - March 4, 2025

Neutra Corp to Launch New Site Management Organization in Clinical Research, Focusing on Patient Centricity 

Neutra Corp - January 27, 2025

Neutra Corp Announces Clinical Research Pilot Program to Address Growing Industrywide Need for Site Management Organization Services 

Neutra Corp - December 29, 2023

Neutra Reflects on 2023 and Looks Forward to 2024

Neutra Corp - October 30, 2023

Neutra Announces Strategic and Financial Value Creation Plan

Neutra Corp - May 15, 2023

Neutra Nearing Expansion Into Growing Health, Wellness and Life Sciences Sector

Neutra Corp - March 28, 2023

Neutra's Strategic Move to Put the Organization in Position to Achieve Its Plans for Growth

Neutra Corp - January 30, 2023

Neutra Executes LOI to Acquire Private Clinical Research Site Management Organization

Financial Disclosures

Neutra Corp. - 10-K Filing Date 04/30/2025 Ending Date 01/31/2025

Neutra Corp. - NT 10-K Management Certification Date 04/30/2025 Ending Date 01/31/2025

Neutra Corp. - 10-Q Filing Date 12/20/2024 Ending Date 10/31/2024

Neutra Corp. - 10-Q Filing Date 12/20/2024 Ending Date 07/31/2024

Neutra Corp. - 10-Q Filing Date 12/20/2024 Ending Date 04/30/2024

Neutra Corp. - 10-K Filing Date 12/20/2024 Ending Date 01/31/2024

Neutra Corp. - 10-Q Filing Date 12/15/2023 Ending Date 10/31/2023

Neutra Corp. - 10-Q Filing Date 09/14/2023 Ending Date 07/31/2023

Neutra Corp. - 8-K Filing Date 08/04/2023 Ending Date 08/01/2023

Neutra Corp. - 10-Q Filing Date 06/22/2023 Ending Date 04/30/2023

Neutra Corp. - NT 10-Q Filing Date 06/14/2023 Ending Date 04/30/2023

For Additional Filings, please visit:

SEC Database and OTC Markets

This website is for informational purposes only. The information contained herein is not an offer to sell or a solicitation to buy NTRR securities as defined under the Securities Act of 1933. Potential investors should carefully read all public filings that the Company has made with the Securities and Exchange Commission, including sections entitled "Risk Factors" which can be found on Forms S-1A and 10-K. Prior to making any investment, you should always consult with your financial advisor and legal professional to determine if the investment is suitable for you. This website contains "forward-looking statements" (as such term is defined in the Private Securities Litigation Reform Act of 1995), within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements include any statement that may project, indicate or imply future results, events, performance or achievements. The forward-looking statements contained herein are based on current expectations that involve a number of risks and uncertainties. These statements can be identified by the use of forward-looking terminology such as "believes," "expect," "may," "will," "should," "intend," "plan," "could," "estimate" or "anticipate" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. Given the risks and uncertainties relating to forward-looking statements, investors should not place undue reliance on such statements.

Copyright © 2024 Neutra Corp - All Rights Reserved.


Powered by